Structural requirements for cellular uptake and antisense activity of peptide nucleic acids conjugated with various peptides - PubMed (original) (raw)
. 2006 Dec 19;45(50):14944-54.
doi: 10.1021/bi0606896.
Affiliations
- PMID: 17154532
- DOI: 10.1021/bi0606896
Structural requirements for cellular uptake and antisense activity of peptide nucleic acids conjugated with various peptides
Yvonne Wolf et al. Biochemistry. 2006.
Abstract
Peptide nucleic acids (PNAs) have shown great promise as potential antisense drugs; however, poor cellular delivery limits their applications. Improved delivery into mammalian cells and enhanced biological activity of PNAs have been achieved by coupling to cell-penetrating peptides (CPPs). Structural requirements for the shuttling ability of these peptides as well as structural properties of the conjugates such as the linker type and peptide position remained controversial, so far. In the present study an 18mer PNA targeted to the cryptic splice site of a mutated beta-globin intron 2, which had been inserted into a luciferase reporter gene coding sequence, was coupled to various peptides. As the peptide lead we used the cell-penetrating alpha-helical amphipathic peptide KLAL KLAL KAL KAAL KLA-NH2 [model amphipathic peptide (MAP)] which was varied with respect to charge and structure-forming properties. Furthermore, the linkage and the localization of the attached peptide (C- vs N-terminal) were modified. Positive charge as well as helicity and amphipathicity of the KLA peptide was all required for efficient dose-dependent correction of aberrant splicing. The highest antisense effect was reached within 4 h without any transfection agent. Stably linked conjugates were also efficient in correction of aberrant splicing, suggesting that a cleavable disulfide bond between CPP and PNA is clearly not essential. Moreover, the placement of the attached peptide turned out to be crucial for attaining antisense activity. Coadministration of endosome disrupting agents such as chloroquine or Ca2+ significantly increased the splicing correction efficiency of some conjugates, indicating the predominant portion to be sequestered in vesicular compartments.
Similar articles
- Induction of splice correction by cell-penetrating peptide nucleic acids.
El-Andaloussi S, Johansson HJ, Lundberg P, Langel U. El-Andaloussi S, et al. J Gene Med. 2006 Oct;8(10):1262-73. doi: 10.1002/jgm.950. J Gene Med. 2006. PMID: 16900561 - Evaluation of basic amphipathic peptides for cellular delivery of antisense peptide nucleic acids.
Maier MA, Esau CC, Siwkowski AM, Wancewicz EV, Albertshofer K, Kinberger GA, Kadaba NS, Watanabe T, Manoharan M, Bennett CF, Griffey RH, Swayze EE. Maier MA, et al. J Med Chem. 2006 Apr 20;49(8):2534-42. doi: 10.1021/jm051275y. J Med Chem. 2006. PMID: 16610796 - Enhanced cellular delivery of cell-penetrating peptide-peptide nucleic acid conjugates by photochemical internalization.
Shiraishi T, Nielsen PE. Shiraishi T, et al. Methods Mol Biol. 2011;683:391-7. doi: 10.1007/978-1-60761-919-2_28. Methods Mol Biol. 2011. PMID: 21053145 - Peptide nucleic acids (PNAs) antisense effect to bacterial growth and their application potentiality in biotechnology.
Hatamoto M, Ohashi A, Imachi H. Hatamoto M, et al. Appl Microbiol Biotechnol. 2010 Mar;86(2):397-402. doi: 10.1007/s00253-009-2387-8. Epub 2010 Feb 5. Appl Microbiol Biotechnol. 2010. PMID: 20135118 Review. - Peptide nucleic acids as therapeutic agents.
Nielsen PE. Nielsen PE. Curr Opin Struct Biol. 1999 Jun;9(3):353-7. doi: 10.1016/S0959-440X(99)80047-5. Curr Opin Struct Biol. 1999. PMID: 10361091 Review.
Cited by
- Application of Cell Penetrating Peptides as a Promising Drug Carrier to Combat Viral Infections.
Khairkhah N, Namvar A, Bolhassani A. Khairkhah N, et al. Mol Biotechnol. 2023 Sep;65(9):1387-1402. doi: 10.1007/s12033-023-00679-1. Epub 2023 Jan 31. Mol Biotechnol. 2023. PMID: 36719639 Free PMC article. Review. - Nuclear localization of cell-penetrating peptides is dependent on endocytosis rather than cytosolic delivery in CHO cells.
Zaro JL, Vekich JE, Tran T, Shen WC. Zaro JL, et al. Mol Pharm. 2009 Mar-Apr;6(2):337-44. doi: 10.1021/mp800239p. Mol Pharm. 2009. PMID: 19718791 Free PMC article. - Cellular localization and allele-selective inhibition of mutant huntingtin protein by peptide nucleic acid oligomers containing the fluorescent nucleobase [bis-o-(aminoethoxy)phenyl]pyrrolocytosine.
Hu J, Dodd DW, Hudson RH, Corey DR. Hu J, et al. Bioorg Med Chem Lett. 2009 Nov 1;19(21):6181-4. doi: 10.1016/j.bmcl.2009.09.004. Epub 2009 Sep 6. Bioorg Med Chem Lett. 2009. PMID: 19783436 Free PMC article. - Cellular antisense activity of peptide nucleic acid (PNAs) targeted to HIV-1 polypurine tract (PPT) containing RNA.
Boutimah-Hamoudi F, Leforestier E, Sénamaud-Beaufort C, Nielsen PE, Giovannangeli C, Saison-Behmoaras TE. Boutimah-Hamoudi F, et al. Nucleic Acids Res. 2007;35(12):3907-17. doi: 10.1093/nar/gkm374. Epub 2007 May 30. Nucleic Acids Res. 2007. PMID: 17537815 Free PMC article. - Efficient splicing correction by PNA conjugation to an R6-Penetratin delivery peptide.
Abes S, Turner JJ, Ivanova GD, Owen D, Williams D, Arzumanov A, Clair P, Gait MJ, Lebleu B. Abes S, et al. Nucleic Acids Res. 2007;35(13):4495-502. doi: 10.1093/nar/gkm418. Epub 2007 Jun 21. Nucleic Acids Res. 2007. PMID: 17584792 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous